The B.1.1.529 (omicron) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified on November 25, 2021, in Gauteng province, South Africa. Data regarding the seroprevalence of SARS-CoV-2 IgG in Gauteng before the fourth wave of coronavirus disease 2019 (Covid-19), in which the omicron variant was dominant, are needed.

Matéria original

Anterior

Antibody evasion properties of SARS-CoV-2 Omicron sublineages

Próxima

Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant